Month: <span>June 2017</span>

Home / 2017 / June
Post

New effective treatments for psoriatic arthritis patients

New agents working on different inflammatory aspects of PsA are needed in the treatment of PsA patients living with this chronic immune-mediated disease, which involves both joint and skin symptoms. In the first study, in patients with active PsA who had not previously been prescribed an anti-TNF treatment, tofacitinib (an oral Janus kinase inhibitor under...

Post

New antibiotic effective against drug-resistant bacteria

First selective nucleoside-analog inhibitor of bacterial RNA polymerase Structure of bacterial RNA polymerase, showing the binding sites for the new antibiotic pseudouridimycin (PUM) and the current antibacterial drug rifampin (Rif). PUM has a lower resistance rate and a smaller resistance target than Rif — just 2 to 4 positions where alterations that result in PUM-resistance...

Post

A new drug that ‘switches off’ food cravings is on the horizon after scientists discover the way in which our brains govern hunger

Researchers used a tiny periscope to access part of brain not accessed before Allowed them to gain deeper understanding of how we react to food cues  Certain hunger-promoting neurons can be artificially turned on even when full Hopes that these same neurons can be turned off to reduce food cravings Could help obese people with a’faulty’ hard...

Post

The chili painkiller can that could banish knee pain: Injection could offer six month of relief

Uses a man-made version of chili plant extract trans-capsaicin The drug is designed to be injected at the site of pain  Relieved knee pain among osteoarthritis patients for up to six months  A synthetic version of a medicine traditionally extracted from chili plant relieved knee pain among osteoarthritis patients for up to six months, data...

Post

New oral treatment option for rheumatoid arthritis

Patients suffering from rheumatoid arthritis are treated for around six months with the standard anti-rheumatic agent methotrexate, to which many patients respond very well. However, if they do not respond and no remission or at least reduction in the activity of the disease can be achieved, they are given a combined treatment of methotrexate and...

Post

MIRACLE JAB Heart attack ‘vaccine’ available in just SIX years to knock cholesterol busting statins off the shelves

AN injection that lowers cholesterol to protect against heart attacks will be available within six years, doctors hope. The once-a-year jab, now being tested in clinical trials, would end the need to take daily statin pills for millions of patients. It works by boosting the body’s ability to remove cholesterol from the blood, cutting levels...